Details for New Drug Application (NDA): 202280
✉ Email this page to a colleague
The generic ingredient in ESCITALOPRAM OXALATE is escitalopram oxalate. There are twenty-six drug master file entries for this compound. Fifty-one suppliers are listed for this compound. Additional details are available on the escitalopram oxalate profile page.
Summary for 202280
Tradename: | ESCITALOPRAM OXALATE |
Applicant: | Jubilant Cadista |
Ingredient: | escitalopram oxalate |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Pharmacology for NDA: 202280
Mechanism of Action | Serotonin Uptake Inhibitors |
Suppliers and Packaging for NDA: 202280
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
ESCITALOPRAM OXALATE | escitalopram oxalate | TABLET;ORAL | 202280 | ANDA | Jubilant Cadista Pharmaceuticals Inc. | 59746-279 | 59746-279-01 | 100 TABLET, FILM COATED in 1 BOTTLE (59746-279-01) |
ESCITALOPRAM OXALATE | escitalopram oxalate | TABLET;ORAL | 202280 | ANDA | Jubilant Cadista Pharmaceuticals Inc. | 59746-279 | 59746-279-05 | 500 TABLET, FILM COATED in 1 BOTTLE (59746-279-05) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | EQ 5MG BASE | ||||
Approval Date: | Sep 12, 2012 | TE: | AB | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | EQ 10MG BASE | ||||
Approval Date: | Sep 12, 2012 | TE: | AB | RLD: | No |
Profile for product number 003
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | EQ 20MG BASE | ||||
Approval Date: | Sep 12, 2012 | TE: | AB | RLD: | No |
Complete Access Available with Subscription